Latest Nasdaq Listings News

Pinnacle Minerals Ltd is fast-tracking its U.S. growth by initiating a listing on the OTCQB Market and appointing key U.S. advisers to boost investor engagement and capital access.

Eclipse Metals has commenced diamond drilling at its Greenland rare earth project, backed by a $4 million placement to expand and upgrade its resource. The move aligns with strategic plans for a Nasdaq dual listing amid growing global supply chain concerns.

Eclipse Metals announces plans for a NASDAQ dual listing to boost its rare earth elements strategy and tap into North American capital markets, while maintaining its ASX presence.

Eclipse Metals has raised $4 million to accelerate drilling and resource upgrades at its Greenland rare earths project, while preparing for a potential NASDAQ dual listing.

Trigg Minerals is advancing its strategy to list on the U.S. NASDAQ, weighing options including a dual listing and potential SPAC mergers, while planning a name change to reflect its evolving focus.

Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.

Ovanti Limited intensifies its pursuit of a NASDAQ dual-listing or SPAC transaction, engaging multiple SPACs and restructuring its advisory agreement to unlock significant shareholder value.

333D Limited has responded to ASX queries, clarifying that its Bitcoin Treasury Management Policy approval is not price sensitive, while disclosing a $370,500 Bitcoin acquisition funded partly by R&D tax incentives.

AXP Energy has updated its resource disclosures and is accelerating its gas-to-power strategy to fuel bitcoin mining operations in Oklahoma, leveraging proven oil fields and strong industry partnerships.

Resolution Minerals and Snow Lake Resources have mutually agreed to halt their proposed transaction over the Horse Heaven Project, citing commercial disagreements despite no material due diligence issues.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

Zip Co Limited’s FY25 results reveal a powerful US market expansion driving a 147% rise in cash earnings and a strategic Nasdaq dual listing consideration.